15 Serious infections and associated risk factors in patients receiving infliximab and immunotherapies for children with inflammatory bowel disease: DEVELOP registry data.
| Autor: | Baldassano, R., Colletti, R., Cucchiara, S., Dubinsky, M., Escher, J., Faubion, W., Fell, J., Gold, B., Griffiths, A., Hyams, J., Koletzko, S., Kugathasan, S., Markowitz, J., Ruemmele, F.M., Veereman, G., Callegari, P., Molenda, M., Tang, K.L., Wright, R., Winter, H. |
|---|---|
| Zdroj: | Journal of Crohn's & Colitis; Feb2013 Supplement, Vol. 7, pS7-S8, 0p |
| Databáze: | Supplemental Index |
| Externí odkaz: |
|